EFFICACY OF INTRAGASTIC BALLOONS IN WEIGHT REDUCTION
Abstract
The endoscopic application of intragastric balloons (IGB) is a very effective non-surgical technique in the treatment of excess body weight. The aim of this study was to аnalyze the effectiveness of IGB in obesity treatment and tо compare the results of using different types of IGB. The study included 80 overweight patients with a BMI between 25 and 40 kg/m2, treated with the application of two types of IGB (Spatz and Endd-Ball). Weight control of patients was performed 48 hours, 7 days, 14 days, 30 days, 90 days, and 180 days after the IGB placement, as well as 6 months after the IGB removal. Six months after application, the IGBs were endoscopically removed. The number of kilograms lost, as well as the change in BMI, were analyzed. A comparison between the results obtained with the two different types of IGB (Spatz and Edd-Ball) was made. For statistical processing of the data, a database was created in the statistical program SPSS for Windows, .The average weight loss 6 months after the application of IGB was about 15 kg. Comparing BMI values ​​before and 6 months after the intervention showed a statistically significant decrease in BMI after the intervention (p= 0.00) and confirmed the efficacy of IGB. Comparing the lost kilograms in relation to the type of IGB applied did not show statistically significant differences. The application of IGB has shown to be an effective method for weight loss.
Keywords: obesity, intragastric balloon, therapy, endoscopy.
References
2. Fulton M, Srinivasan VN. Obesity, Stigma And Discrimination. 2021 Mar 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 32119458.
3. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020;360:1–8.
4. Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric andmetabolic therapies:new and emerging technologies. Gastroenterology 2017;152:1791-801.
5. Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT. Current status of intragastric balloon for obesity treatment. World J Gastroenterol 2016;22:5495-504.
6. Gomez V, Woodman G, Abu Dayyeh BK. Delayed gastric emptying as a proposed mechanism of action during intragastric balloon therapy:results of a prospective study. Obesity (Silver Spring) 2016;24:1849-53.
7. Swidnicka-Siergiejko A, Wroblewski E, Andrzej D. Endoscopic treatmentof obesity. Can J Gastroenterol 2011;25:627-33.
8. Kentish SJ, Page AJ. The role of gastrointestinal vagal afferent fibres inobesity. J Physiol 2015;593:775-86.
9. Abu Dayyeh BK, Eaton LL, Woodman G, et al. A Randomized, Multi-Center Study to Evaluate the Safety and Effectiveness of an Intragastric Balloon As an Adjunct to a Behavioral Modification Program, in Comparison With a Behavioral Modification Program Alone in the Weight Management of Obese Subjects. Gastrointestinal Endoscopy 2015;81:AB147.
10. Russo T, Aprea G, Formisano C, et al. BioEnterics Intragastric Balloon (BIB) versus Spatz Adjustable Balloon System (ABS): Our experience in the elderly. Int J Surg 2017;38:138-40.
11. Daniel F, Abou Fadel C, Houmani Z, et al. Spatz 3 Adjustable Intragastric Balloon: Long-Term Safety Concerns. Obes Surg 2016;26:159-60.
12. Trang J, Lee SS, Miller A, et al. Incidence of nausea and vomiting after intragastric balloon placement in bariatric patients - A systematic review and meta-analysis. Int J Surg 2018;57:22-9.
13. Gollisch KSC, Raddatz D. Endoscopic intragastric balloon: a gimmick or a viable option for obesity?. Ann Transl Med. 2020;8(Suppl 1):S8.
14. Choi СЈ, Choi HS. Various Intragastric Balloons Under Clinical Investigation.Clin Endosc 2018;51:407-15.
15. Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons:a 12-month pilot trial in endoscopic weight loss management.Obes Surg 2011;21:1499-507.
16. Layec S, Val-Laillet D, Heresbach D, et al. Gastric tone, volume and emptying after implantation of an intragastric balloon for weight control. Neurogastroenterol Motil 2010;22:1016-21, e265-6.
17. Trang J, Lee SS, Miller A, et al. Incidence of nausea and vomiting after intragastric balloon placement in bariatric patients - A systematic review and meta-analysis. Int J Surg 2018;57:22-9.
18. Zheng Y, Wang M, He S, et al. Short-term effects of intragastric balloon in association with conservative therapy on weight loss: a meta-analysis. J Transl Med 2015;13:246.
19. Abu Dayyeh BK, Eaton LL, Woodman G, et al. A Randomized, Multi-Center Study to Evaluate the Safety and Effectiveness of an Intragastric Balloon As an Adjunct to a Behavioral Modification Program, in Comparison With a Behavioral Modification Program Alone in the Weight Management of Obese Subjects. Gastrointestinal Endoscopy 2015;81:AB147
20. Yorke E, Switzer NJ, Reso A, et al. Intragastric Balloon for Management of Severe Obesity: a Systematic Review. Obes Surg 2016;26:2248-54.
21. Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc 2015;82:425-38.e5.
22. Papavramidis TS, Grosomanidis V, Papakostas P, et al. Intragastric balloon fundal or antral position affects weight loss and tolerability. Obes Surg 2012;22:904-9.
23. Russo T, Aprea G, Formisano C, et al. BioEnterics Intragastric Balloon (BIB) versus Spatz Adjustable Balloon System (ABS): Our experience in the elderly. Int J Surg 2017;38:138-40.
24. Abdelhamid SA, Kamel MS. A prospective controlled study to assess the antiemetic effect of midazolam following intragastric balloon insertion. J Anaesthesiol Clin Pharmacol 2014;30:383-6.
25. Van Hee R, Van Wiemeersch S, Lasters B, et al. Use of anti-emetics after intragastric balloon placement: experience with three different drug treatments. Obes Surg 2003;13:932-7.
